1706999 the impact of digital twin technology on hbA1c reduction and ASCVD risk in participants enrolled for type 2 diabetes remission: outcomes of RCCT at 1 year
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cardiovascular benefits were observed in the DT group, including significant reductions in systolic and diastolic blood pressure.
“Cardiovascular benefits were another key outcome, with significant reductions in systolic and diastolic blood pressure, substantial weight loss, and a shift towards a lower ASCVD risk profile in the DT group (21).”
From Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control (2024) · cites this paper as [21]
The source’s Abstract (page not specified) reports a significant reduction in estimated 10-year ASCVD risk and a shift toward a lower-risk profile in the DT group. It does not report systolic or diastolic blood-pressure reductions, or the weight loss also included in the citing sentence. (LLM, conf=0.86)
Experimental — accuracy not yet measuredCardiovascular benefits were observed in the DT group, including substantial weight loss.
“Cardiovascular benefits were another key outcome, with significant reductions in systolic and diastolic blood pressure, substantial weight loss, and a shift towards a lower ASCVD risk profile in the DT group (21).”
From Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control (2024) · cites this paper as [21]
The Results in the indexed abstract report a marked shift toward lower ASCVD risk in the DT group after one year. They do not report substantial weight loss or significant reductions in systolic or diastolic blood pressure, which the citing sentence also attributes to this source. No page number is available for the passage. (LLM, conf=0.88)
Experimental — accuracy not yet measuredDT technology has significant cardiovascular benefits.
“DT technology has shown significant cardiovascular benefits as well.”
From Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control (2024) · cites this paper as [21]
Cardiovascular benefits were observed in the DT group, including a shift towards a lower ASCVD risk profile.
“Cardiovascular benefits were another key outcome, with significant reductions in systolic and diastolic blood pressure, substantial weight loss, and a shift towards a lower ASCVD risk profile in the DT group (21).”
From Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control (2024) · cites this paper as [21]
The DT group demonstrated a shift toward a lower ASCVD risk profile, with 76.6% of participants categorized as low risk at one year compared to 49.1% at baseline, and high-risk category decreasing from 8.1% to 0.9%.
“The DT group also demonstrated a marked shift towards a lower ASCVD risk profile, with 76.6% of participants categorized as low risk at one year compared to 49.1% at baseline. High-risk category reductions were more pronounced in the DT group, decreasing from 8.1% to 0.9% (21).”
From Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control (2024) · cites this paper as [21]
The DT technology's broader benefits in cardiovascular health, liver function, and weight management indicate its potential as a comprehensive solution for managing metabolic syndrome.
“Additionally, the DT technology’s broader benefits in cardiovascular health (21), liver function (18), and weight management (18) indicate its potential as a comprehensive solution for managing the complex challenges of metabolic syndrome.”
From Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control (2024) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
Cited by 3
- Authors
- Shamanna, P., Shamanna, P., Dharmalingam, M., Vadavi, A., Keshavamurthy, A., Thajudeen, M., Bhonsley, S., & Joshi, S.
- Affiliations
- M.S. Ramaiah Medical College (IN)
- Sudha Hospital and Medical Research Centre (IN)
- Lilavati Hospital & Research Centre (IN)
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2024-05
- Volume
- 30
- Issue
- 5
- Pages
- S78
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W4396740550
- Cited by
- 3
- References
- 0
- Citations by year
- 2026: 1 · 2024: 2
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Practice (publishedVersion)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- digital twin, type 2 diabetes remission, HbA1c reduction, atherosclerotic cardiovascular disease risk, artificial intelligence, Internet of Things, personalized nutrition, mobile health apps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
